Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shot could tame tough eczema in adults

NCT ID NCT07321951

Recruiting now Disease control Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 16 times

Summary

This study tests an experimental drug called SHR-1819 in 200 adults with moderate-to-severe atopic dermatitis (a type of eczema). The goal is to see if it can reduce skin redness, itching, and rash. Participants will receive either the drug or a placebo injection, and researchers will track improvements and side effects over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MODERATE-TO-SEVERE ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dermatology Hospital of Southern Medical University

    RECRUITING

    Guangzhou, Guangdong, 510091, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Hangzhou Third People's Hospital

    RECRUITING

    Hangzhou, Zhejiang, 310009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

MODERATE-TO-SEVERE ATOPIC DERMATITIS